Post-tPA Hemorrhage in CVA: Difference between revisions
No edit summary |
(Text replacement - "==References== " to "==References== <references/> ") |
||
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Consider if patient develops: | |||
**Decreased LOC | |||
**Increased weakness | |||
**New headache | |||
**Sudden rise in BP | |||
==Management== | ==Management== | ||
*Stop tPA | |||
*Head CT | |||
**If no bleeding: resume tPA | |||
**If bleeding: | |||
***Consider fibrinogen replacement | |||
***Recheck CBC, coags fibrinogen levels | |||
***Prepare 6-8 units cryoprecipitate | |||
***Prepare 6-8 units platelets | |||
==See Also== | ==See Also== | ||
| Line 20: | Line 20: | ||
*[[CVA (Main)]] | *[[CVA (Main)]] | ||
== | ==References== | ||
<references/> | |||
[[Category:Neurology]] | |||
[[Category: | |||
Revision as of 01:13, 24 July 2017
Background
- Consider if patient develops:
- Decreased LOC
- Increased weakness
- New headache
- Sudden rise in BP
Management
- Stop tPA
- Head CT
- If no bleeding: resume tPA
- If bleeding:
- Consider fibrinogen replacement
- Recheck CBC, coags fibrinogen levels
- Prepare 6-8 units cryoprecipitate
- Prepare 6-8 units platelets